Peishu Liu

429 total citations
18 papers, 303 citations indexed

About

Peishu Liu is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Immunology. According to data from OpenAlex, Peishu Liu has authored 18 papers receiving a total of 303 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Reproductive Medicine, 8 papers in Obstetrics and Gynecology and 4 papers in Immunology. Recurrent topics in Peishu Liu's work include Endometriosis Research and Treatment (8 papers), Uterine Myomas and Treatments (7 papers) and Ovarian cancer diagnosis and treatment (4 papers). Peishu Liu is often cited by papers focused on Endometriosis Research and Treatment (8 papers), Uterine Myomas and Treatments (7 papers) and Ovarian cancer diagnosis and treatment (4 papers). Peishu Liu collaborates with scholars based in China, Canada and United States. Peishu Liu's co-authors include Jingjing Lu, Xuan Wei, Jing Zhao, Linlin Zhang, Xuan Wei, Hao Yu, Jing Zhao, Wei Xuan, Rui Li and Xiaolei Zhang and has published in prestigious journals such as Medicine, BioMed Research International and Cell Cycle.

In The Last Decade

Peishu Liu

18 papers receiving 300 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peishu Liu China 13 155 86 77 69 40 18 303
Chloe Karpinskyj United Kingdom 9 182 1.2× 98 1.1× 116 1.5× 35 0.5× 118 3.0× 12 405
Eva Baxter Australia 8 82 0.5× 114 1.3× 159 2.1× 25 0.4× 49 1.2× 10 334
Gabriel Lindahl Sweden 9 207 1.3× 45 0.5× 107 1.4× 52 0.8× 43 1.1× 22 425
E Bai China 8 63 0.4× 19 0.2× 114 1.5× 29 0.4× 22 0.6× 14 272
Jiao Xiao China 8 120 0.8× 14 0.2× 168 2.2× 36 0.5× 60 1.5× 15 358
Susanne Schüler‐Toprak Germany 13 95 0.6× 34 0.4× 136 1.8× 41 0.6× 96 2.4× 23 378
Irene Aguilera‐Barrantes United States 8 37 0.2× 96 1.1× 133 1.7× 15 0.2× 93 2.3× 14 315
Yukihiro Hirata Japan 8 65 0.4× 22 0.3× 181 2.4× 38 0.6× 86 2.1× 12 336
Qinyang Xu China 12 40 0.3× 31 0.4× 248 3.2× 59 0.9× 153 3.8× 19 398
Tadayuki Kasai Japan 10 244 1.6× 246 2.9× 61 0.8× 39 0.6× 17 0.4× 11 383

Countries citing papers authored by Peishu Liu

Since Specialization
Citations

This map shows the geographic impact of Peishu Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peishu Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peishu Liu more than expected).

Fields of papers citing papers by Peishu Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peishu Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peishu Liu. The network helps show where Peishu Liu may publish in the future.

Co-authorship network of co-authors of Peishu Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Peishu Liu. A scholar is included among the top collaborators of Peishu Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peishu Liu. Peishu Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Huang, Zhen, Li Li, Shu Yao, et al.. (2018). Diagnostic accuracy of frozen section analysis of borderline ovarian tumors: a meta-analysis with emphasis on misdiagnosis factors. Journal of Cancer. 9(16). 2817–2824. 17 indexed citations
2.
Huang, Zhen, Kun Song, Xing Sheng Yang, et al.. (2017). Incidence of venous thromboembolism following the neoadjuvant chemotherapy regimen for epithelial type of ovarian cancer. Medicine. 96(42). e7935–e7935. 19 indexed citations
3.
4.
Wu, Yan, et al.. (2017). Luteal-phase protocol in poor ovarian response: a comparative study with an antagonist protocol. Journal of International Medical Research. 45(6). 1731–1738. 9 indexed citations
5.
Ding, Ning, Hong Zhang, Shan Su, et al.. (2017). Emodin Enhances the Chemosensitivity of Endometrial Cancer by Inhibiting ROS-Mediated Cisplatin-resistance. Anti-Cancer Agents in Medicinal Chemistry. 18(7). 1054–1063. 15 indexed citations
7.
Chen, Hu, Taotao Dong, Rui Li, et al.. (2016). Emodin inhibits epithelial to mesenchymal transition in epithelial ovarian cancer cells by regulation of GSK-3β/β-catenin/ZEB1 signaling pathway. Oncology Reports. 35(4). 2027–2034. 32 indexed citations
8.
Mao, Hongluan, et al.. (2016). Can postoperative GnRH agonist treatment prevent endometriosis recurrence? A meta-analysis. Archives of Gynecology and Obstetrics. 294(1). 201–207. 28 indexed citations
9.
Lu, Jingjing, et al.. (2016). Periostin Facilitates the Epithelial-Mesenchymal Transition of Endometrial Epithelial Cells through ILK-Akt Signaling Pathway. BioMed Research International. 2016. 1–8. 33 indexed citations
10.
Lu, Jingjing, et al.. (2016). Emodin Inhibits the Epithelial to Mesenchymal Transition of Epithelial Ovarian Cancer Cells via ILK/GSK-3β/Slug Signaling Pathway. BioMed Research International. 2016. 1–16. 23 indexed citations
11.
Li, Rui, et al.. (2016). Elevated periostin in serum and peritoneal washing fluids as potential biomarkers for endometriosis. Gynecological Endocrinology. 32(11). 900–903. 2 indexed citations
12.
Zhao, Jing, et al.. (2015). Risk of endometrial polyps in women with endometriosis: a meta-analysis. Reproductive Biology and Endocrinology. 13(1). 103–103. 20 indexed citations
13.
Xu, Xiaoxuan, et al.. (2015). Endometrial ILKAP expression among patients with endometriosis and its association with clinical characteristics. International Journal of Gynecology & Obstetrics. 130(1). 23–26. 1 indexed citations
14.
Xu, Xiaoxuan, et al.. (2015). Periostin Enhances Migration, Invasion, and Adhesion of Human Endometrial Stromal Cells Through Integrin-Linked Kinase 1/Akt Signaling Pathway. Reproductive Sciences. 22(9). 1098–1106. 23 indexed citations
15.
Liu, Ruihan, et al.. (2014). Celecoxib induces epithelial-mesenchymal transition in epithelial ovarian cancer cells via regulating ZEB1 expression. Archives of Gynecology and Obstetrics. 291(6). 1361–1369. 10 indexed citations
16.
Yu, Hao, Linlin Zhang, & Peishu Liu. (2014). CXCR7 signaling induced epithelial–mesenchymal transition by AKT and ERK pathways in epithelial ovarian carcinomas. Tumor Biology. 36(3). 1679–1683. 25 indexed citations
17.
Shen, Liang, et al.. (2012). Characterization of periostin expression in human endometrium and endometriotic lesions. Gynecological Endocrinology. 28(10). 815–818. 13 indexed citations
18.
Mercado‐Uribe, Imelda, Daniel Rosen, Bin Chang, et al.. (2010). Induction of papillary carcinoma in human ovarian surface epithelial cells using combined genetic elements and peritoneal microenvironment. Cell Cycle. 9(1). 140–146. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026